SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-21-142530
Filing Date
2021-11-22
Accepted
2021-11-22 16:31:09
Documents
1
Period of Report
2021-10-21

Document Format Files

Seq Description Document Type Size
1 FORM 4/A tm2133588-2_4a.html 4/A  
1 FORM 4/A tm2133588-2_4a.xml 4/A 3599
  Complete submission text file 0001104659-21-142530.txt   5134
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EYEGATE PHARMACEUTICALS INC. 271 WAVERLY OAKS RD., STE 108 WALTHAM MA 02452
Business Address
Daniels Eric Joseph (Reporting) CIK: 0001892943 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36672 | Film No.: 211432943